Vitamin B5 could be the key to treating a rare genetic disease, a study has found.

Published Date: 08 Mar 2023

A study by Concordia undergraduate students suggests that a simple vitamin can cure a rare but life-threatening disease.

Read Full News

Latest News

Congo Reports Ebola Death in New Province, Official Says

Democratic Republic of Congo health authorities have identified a person who has died from Ebola ⁠in a province not previously affected by the ongoing outbreak, an official...

Once-Weekly Oral ART Matches Daily ART for Viral Suppression

The potential arrival of once-weekly oral ART options could be particularly important for those who face challenges of stigma or adherence difficulties, advocate says.

UK Regulator Endorses Safety Of Childhood Vaccination

Britain's health regulator on Wednesday reaffirmed the safety of ⁠childhood vaccination and endorsed it as an effective and safe way ⁠to safeguard against serious infectious...

Vaccination in Pregnancy Embraced by Ob/Gyns

Long the primary purview of pediatricians, routine discussion and administration of vaccines is an increasing focus of obstetric clinicians.

Controlled Breathing May Help Cut Addiction Cravings

Controlled breathing interventions are associated with reduced craving in patients with substance use disorders compared with control interventions, new research shows.

Meningococcal B Vaccine May Cut Gonorrhea Risk in Teens

A multicomponent meningococcal B vaccine showed modest protection against gonorrhea in a high-burden population, a study shows.

Todays Updates

SBRT vs IMRT: Better for Bowel Symptoms, Not Cancer Control

For men with intermediate-risk prostate cancer, SBRT may beat longer-course radiotherapy in some measures of quality of life, but not disease-free survival.

Can Electronic PRO Monitoring Ease Fatigue in Breast Cancer?

Weekly electronic symptom monitoring was associated with improved fatigue and physical functioning in a randomized trial of patients with metastatic breast cancer.

FDA Approves Iberdomide Combo for Multiple Myeloma

Outcomes improve when a novel, first-in-class immunomodulatory drug is combined with daratumumab and dexamethasone in previously treated patients.

Todays Updates

SBRT vs IMRT: Better for Bowel Symptoms, Not Cancer Control

For men with intermediate-risk prostate cancer, SBRT may beat longer-course radiotherapy in some measures of quality of life, but not disease-free survival.

Can Electronic PRO Monitoring Ease Fatigue in Breast Cancer?

Weekly electronic symptom monitoring was associated with improved fatigue and physical functioning in a randomized trial of patients with metastatic breast cancer.

FDA Approves Iberdomide Combo for Multiple Myeloma

Outcomes improve when a novel, first-in-class immunomodulatory drug is combined with daratumumab and dexamethasone in previously treated patients.

Latest News

Democratic Republic of Congo health authorities have identified a person who has died from Ebola ⁠in a province not previously affected by the ongoing outbreak, an official...

The potential arrival of once-weekly oral ART options could be particularly important for those who face challenges of stigma or adherence difficulties, advocate says.

Britain's health regulator on Wednesday reaffirmed the safety of ⁠childhood vaccination and endorsed it as an effective and safe way ⁠to safeguard against serious infectious...

Long the primary purview of pediatricians, routine discussion and administration of vaccines is an increasing focus of obstetric clinicians.

Controlled breathing interventions are associated with reduced craving in patients with substance use disorders compared with control interventions, new research shows.

A multicomponent meningococcal B vaccine showed modest protection against gonorrhea in a high-burden population, a study shows.

News All Time

Senate Confirms Schwartz to Lead CDC

The long-time public servant is leaving a position with UnitedHealth to return to the health agency.

Congo Intercepts Boat That Carried Suspected Ebola Case

Congolese health authorities have intercepted a boat carrying 200 people to the capital ⁠Kinshasa after a passenger who had disembarked earlier died on July 25. after...

CDC Expands Largest Known Cyclosporiasis Outbreak to 15 States, Washington Post Reports

The U.S. CDC is adding six more states to the cyclosporiasis outbreak linked to iceberg lettuce, widening ⁠the number of affected states to 15, the Washington Post reported...

Moderna Begins First Human Trial of Bundibugyo Ebola Vaccine

Moderna said it has begun its first human trial of an experimental vaccine to ⁠protect against Bundibugyo ebolavirus, a strain that has killed more than 1650 people so far.

Racial, Age Inequities Evident in Lenacapavir PrEP Uptake

Researchers also find low rates of uptake for those with high copays or without commercial insurance, suggesting cost barriers to uptake.

Review Reproductive Health Regularly With CF Patients

Recent research emphasizes the safety of contraception and greater potential for pregnancy.

A Single US Measles Outbreak Can Cost Millions of Dollars, Study Estimates

The overall cost of containing a 2025 measles outbreak in New Mexico was nearly $5.4 million, a new study estimates.

Infants Face Higher Risks for Common Respiratory Infections

Infants face higher risks for respiratory infections requiring medical care than older children, although many infections remain asymptomatic or are mostly managed at home.

Cyclosporiasis Cases in Michigan Rise to 10,773 in Ongoing Outbreak

Michigan reported 10,773 cases linked to a cyclosporiasis outbreak on Friday, up 387 from the previous day, the ⁠state health department said in its latest...

Finland Detects African Swine Fever for First Time

Finland has detected African swine fever for the first time after ⁠laboratory tests found the virus in three wild boar piglets in eastern Finland, ⁠the Finnish Food...

Congo's Ebola Outbreak Started At Least in January, Report Shows

Democratic Republic of Congo's fast-spreading Ebola outbreak started in January, or even earlier, in the ⁠eastern Ituri province, a report published in the journal Science...

Escalating Crohn’s Care: The Case for Dual Therapy

Dr Dana Lukin outlines patient selection for combination therapy in Crohn’s disease and highlights the most promising dual-targeted strategies.

Cyclosporiasis Cases in Michigan Surpass 10,000 in Ongoing Outbreak

Michigan health officials reported 10,077 cases of cyclosporiasis on Wednesday, an increase of 397 ⁠cases since their last update a day earlier.

Trump Administration Unfreezes $600 Million for Gavi for Global Vaccine Effort

The Trump administration said on Wednesday it will immediately release $600 million in congressionally appropriated funds for vaccines for ⁠the world's poorest countries...

IGRA vs TST: Which Test Better Detects Latent Tuberculosis?

Tuberculin skin test positivity exceeds interferon-gamma release assay positivity among healthcare workers and first responders, a meta-analysis finds.

UK Reports Rise in Cyclospora Infections Linked to Mexico Travel

The UK Health Security Agency (UKHSA) said on Thursday it was seeing a sharp rise in cyclospora infections among travellers ⁠returning from Mexico and urged people to follow...

Recommended News For You

Disparities in use of MRI to detect prostate cancer: Race and location may influence testing

For the treatment of vestibular schwannomas in neurofibromatosis type 2, stereotactic radiosurgery has been found to be effective.

Older Adults With Advanced Cancer Prioritize Quality of Life

FDA approves rivanetin as the first-line treatment for lung cancer.

Prostate cancer relapse after radiotherapy is strongly predicted by biological markers.

Timely ‘Nudges’ Help Spur Talks on Patient Care Goals

Higher levels of HIF2α found to slow down aggressive childhood cancer

Recommended Articles For You

The Benefits and Risks of Thrombolytics: A Comprehensive Guide  

Comprehensive Updates in Hematology and Quality Improvement 

The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies 

Rehabilitation of Physical Endurance Following Prolonged Cytopenic States 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Imfinzi + Imjudo, EU approved for patients with advanced lung cancer and non-small cell lung cancer: AstraZeneca

2.

One CAR T-Cell Therapy for Multiple Myeloma Tops Another in Propensity Matched Study

3.

It has been discovered that personalized dosing in the treatment of prostate cancer improves patient outcomes.

4.

According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.

5.

Momelotinib, a JAK inhibitor, has FDA approval to treat adult myelofibrosis in anemic patients.

1.

Emerging Advances in Hematology and Quality Improvement

2.

Practical Breakthroughs in Oncology Across Clinical Settings

3.

Nuclear Medicine's Role in Battling Women's Cancers

4.

Genetic Screening: A Game Changer in Cancer Prevention

5.

Exploring the Pleomorphic Adenoma: A Unique and Varied Tumor

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

1.

Navigating the Complexities of Ph Negative ALL - Part VII

2.

An In-Depth Look At The Signs And Symptoms Of Lymphoma

3.

Signs and Symptoms of Leukemia

4.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot